Can I Take 40 mg of Melatonin a Night?

Taking 40 mg of melatonin is roughly ten times the dose that produces the best sleep results in clinical research, and for most people it offers no additional benefit while raising the risk of side effects and drug interactions. Melatonin’s sleep-promoting effects plateau around 4 mg per day, beyond which extra milligrams flood past the receptors that actually regulate your sleep-wake cycle. Doses in the 20–50 mg range do appear in medical research, but almost exclusively for purposes unrelated to sleep, such as experimental cancer support or neuroprotection trials run under close medical supervision.

Why Sleep Benefits Plateau Well Below 40 mg

A 2024 dose-response meta-analysis of randomized controlled trials found that melatonin’s ability to shorten the time it takes to fall asleep and extend total sleep time peaked at about 4 mg per day.1PubMed. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis Going higher didn’t produce meaningfully better results. The reason comes down to how melatonin receptors work: once the receptors in your brain that govern circadian signaling are saturated, additional melatonin has nowhere useful to bind for sleep purposes. A review on chronobiological applications noted that circadian readjustment requires doses only in the lower milligram range, consistent with receptor binding capacity, and that doses exceeding receptor saturation are “unsuitable for chronobiological purposes.”2PubMed Central. Divergent Importance of Chronobiological Considerations in High- and Low-dose Melatonin Therapies

In practical terms, if you are taking 40 mg to sleep, most of that melatonin is simply being metabolized and excreted without doing anything your body’s sleep system can use. The same meta-analysis also found that taking melatonin about three hours before your desired bedtime improved results compared to the common practice of taking it 30 minutes before bed. So timing matters at least as much as dose, and probably more than piling on extra milligrams.

What Happens in Your Body When You Take a Very High Dose

Your liver processes melatonin primarily through a single enzyme pathway called CYP1A2, which handles roughly 93% of melatonin metabolism.3PubMed Central. Unraveling Cannabidiol’s Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections At standard sleep doses, your liver clears melatonin quickly, typically within a few hours. At 40 mg, you’re asking that same enzyme system to handle a much larger load, which keeps blood levels elevated for longer. A systematic review confirmed that higher oral doses produce a dose-dependent rise in blood and urine melatonin levels, and that these elevated levels are maintained above a given threshold for a longer period than lower doses.4PubMed. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature

That lingering melatonin isn’t harmless. Some people report grogginess, headaches, and daytime drowsiness even at moderate doses. At very high doses, you could also experience vivid dreams, nausea, or dizziness. A more subtle concern is that prolonged high blood levels of melatonin can blur the timing signal your body uses to distinguish day from night, potentially worsening the very circadian disruption you’re trying to fix.

One reassuring finding: taking exogenous melatonin, even at high doses over extended periods, does not appear to suppress your body’s own melatonin production. A study giving 50 mg daily for 37 days to a blind subject found no change in the endogenous melatonin profile afterward.5PubMed. The amplitude of endogenous melatonin production is not affected by melatonin treatment in humans Your pineal gland keeps doing its job regardless. But that doesn’t mean megadoses are safe for other reasons.

Drug Interactions Get More Concerning at High Doses

Because melatonin is metabolized almost entirely by CYP1A2, anything else that uses or inhibits that same liver enzyme pathway can create problems. At a low dose, competitive pressure on CYP1A2 is minimal. At 40 mg, you’re essentially flooding the pathway. A clinical trial of high-dose melatonin in multiple sclerosis patients noted that melatonin at pharmacological doses could saturate the enzymatic capacity of CYP1A2 and related conjugation pathways, potentially causing accumulation of other drugs that share those pathways and raising the risk of liver toxicity.6PubMed Central. Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1)

One interaction worth flagging specifically involves CBD. Research found that cannabidiol acts as a potent inhibitor of CYP1A2-mediated melatonin metabolism, meaning CBD could substantially slow down how quickly your body clears melatonin. Modeling suggested that oral CBD at commonly used doses could increase melatonin exposure by 8 to 12 times.3PubMed Central. Unraveling Cannabidiol’s Bidirectional Regulation of Melatonin Pharmacokinetics via PEPT1/CYP1A2: Mechanistic Insights and Quantitative Projections If you’re already taking 40 mg of melatonin and you add CBD, you could effectively be exposing your body to the equivalent of hundreds of milligrams of melatonin.

Meanwhile, a pharmacological screening of common medications found that everyday drugs like acetaminophen and diazepam did not significantly impair melatonin metabolism at their normal therapeutic concentrations.7PubMed. Potential drug interactions with melatonin So the interaction risk isn’t universal, but it’s real with certain substances. Blood thinners, immunosuppressants, and drugs for diabetes or seizures are among the categories where caution is warranted, especially at high melatonin doses. If you take any prescription medications and are considering a dose anywhere near 40 mg, a conversation with your prescriber isn’t optional.

Older Adults Are Especially Vulnerable to High Doses

Age changes how your body handles melatonin in ways that make high doses particularly risky for older adults. Peak blood concentrations after an oral dose have been reported as up to 240% higher in older adults compared to younger adults taking the same amount.8PubMed Central. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults Even studies that found smaller differences still observed roughly 50% higher average blood concentrations with greater individual variability in people over 50. The same review noted that the same dose given to an older person would reasonably be expected to produce more pronounced effects, and that combined with high variability in absorption, there’s a compounded risk of unpredictable blood levels.

Liver function matters too. Melatonin clearance slows in people with liver disease, which becomes increasingly common with age. Research on pharmacokinetics in older adults confirmed that while melatonin did not appear to damage kidney or liver function after six weeks of use, patients with existing liver damage showed delayed onset and peak of melatonin at night, along with daytime levels significantly higher than normal.9PubMed Central. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults For an older adult with any degree of liver impairment, 40 mg could behave like a much larger dose once it reaches the bloodstream.

The practical takeaway: if you’re over 60 and taking melatonin for sleep, you almost certainly need less than a younger person, not more. Starting at 0.5–1 mg and adjusting upward only if needed is a more sensible approach than jumping to double-digit doses.

The Label Problem Might Mean You’re Already Getting More Than You Think

A 2024 U.S. survey of 110 melatonin dietary supplement products found that actual melatonin content ranged from 0% to 667% of what the label declared.10PubMed. A Survey of Melatonin in Dietary Supplement Products Sold in the United States That’s not a typo. Some products contained nearly seven times the amount stated on the bottle. Others contained essentially none. If you’re intentionally taking a 40 mg pill, you could be getting anywhere from almost nothing to over 250 mg of actual melatonin.

This is a consequence of melatonin’s regulatory status. In the United States, melatonin is classified as a dietary supplement, not a drug, so it’s not subject to the same manufacturing standards that pharmaceutical products undergo. No independent body verifies potency before products reach store shelves. In countries with tighter supplement regulation, the picture looks different. A study of melatonin products sold in Lithuania found that measured content generally fell within a narrow range of the labeled amount, with only one product exceeding a 20% margin.11Chemija. Determination of melatonin in sleep supplements by high-performance liquid chromatography

This labeling inconsistency introduces a hidden variable into any dosing decision, but it’s especially concerning at high intended doses. If you aim for 40 mg and your particular product runs hot, you could unknowingly be taking 80, 100, or more milligrams. Looking for third-party tested products with verified potency can reduce this risk, though it doesn’t eliminate it entirely.

When Doctors Actually Use High-Dose Melatonin

It’s worth understanding that doses of 20 mg, 40 mg, and even higher aren’t unheard of in clinical medicine. They just aren’t used for insomnia. High-dose melatonin has been studied as an adjuvant therapy in cancer treatment, where its antioxidant and immunomodulatory properties are of interest rather than its sleep-promoting effect.12PubMed Central. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities Some clinical trials have used doses in the range of 20–300 mg per day for purposes like neuroprotection in progressive multiple sclerosis, where the goal is to saturate receptors and achieve high concentrations in the central nervous system.6PubMed Central. Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1)

These trials run under tight medical oversight, with regular blood work monitoring liver enzymes and metabolic markers. The MELATOMS-1 trial specifically tracked liver safety because of the known risk that high melatonin doses can overwhelm the same enzyme pathways used by other medications. Participants in these studies aren’t self-dosing from a supplement bottle; they’re receiving pharmaceutical-grade melatonin with confirmed potency in a controlled environment.

Research has also explored melatonin’s effects on metabolic health. A systematic review found that melatonin supplementation at 10 mg reduced measures of insulin resistance across various health conditions.13PubMed. Exploring effects of melatonin supplementation on insulin resistance: An updated systematic review of animal and human studies But even in metabolic research, the doses that showed benefit were well below 40 mg. The point is that medical use of high-dose melatonin exists but represents a fundamentally different use case from taking a supplement to help you sleep.

Tolerance and Rebound Insomnia

One common worry about any sleep aid is whether you’ll need progressively higher doses over time, and whether quitting will leave you worse off than when you started. This concern may be part of why some people end up at 40 mg: they started lower, felt it stopped working, and kept escalating. The research here is actually encouraging. A long-term open-label study of prolonged-release melatonin (at standard 2 mg doses) found no evidence of tolerance developing, no rebound insomnia upon stopping, and no suppression of the body’s own melatonin production.14PubMed Central. Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal Participants actually experienced residual benefit after discontinuation, meaning their sleep stayed somewhat improved even after they stopped taking it.

A separate review confirmed that exogenous melatonin does not reduce endogenous melatonin production or cause rebound insomnia.15PubMed Central. Chronic Administration of Melatonin: Physiological and Clinical Considerations This sets melatonin apart from benzodiazepines and Z-drugs, where tolerance and dependence are well-documented. If you feel like melatonin “stopped working,” escalating the dose probably isn’t the answer. You’re more likely dealing with a sleep issue that melatonin alone can’t fix, or your timing is off, or the product’s potency has changed between batches.

Children and Accidental High-Dose Exposure

If there are children in your household and you keep high-dose melatonin products around, the accidental ingestion risk is worth taking seriously. Between 2012 and 2021, U.S. poison control centers received reports of over 260,000 pediatric melatonin ingestions, and the annual number increased by 530% over that decade.16PubMed Central. Pediatric Melatonin Ingestions – United States, 2012-2021 Most cases were unintentional ingestions by children under 5. Five children required mechanical ventilation, and two died. Hospitalizations and serious outcomes rose during the study period.

Emergency department visits for unsupervised pediatric melatonin exposures also surged, increasing over 400% during a similar timeframe.17PubMed Central. Trends in Emergency Department Visits for Unsupervised Pediatric Medication Exposures A 40 mg tablet or a high-concentration gummy that looks like candy is a real hazard. Store melatonin products with the same care you’d give prescription medications: in a child-resistant container, out of sight and reach. The fact that melatonin is sold as a supplement and often marketed in child-friendly forms like gummies contributes to a false sense that it’s harmless in any amount.

If Melatonin Alone Isn’t Enough for Your Sleep

Reaching for 40 mg often reflects frustration with insomnia rather than a calculated dosing decision. If you’ve been escalating your dose and still aren’t sleeping well, the dose was probably never the bottleneck. Melatonin is a circadian signal, not a sedative. It tells your brain that it’s nighttime; it doesn’t knock you out the way a sleeping pill does. If your insomnia stems from anxiety, chronic pain, sleep apnea, or entrenched habits like late-night screen use, more melatonin won’t address the actual cause.

Cognitive behavioral therapy for insomnia, often abbreviated CBT-I, is considered the first-line treatment for chronic insomnia by major sleep medicine organizations. It works by restructuring the behaviors and thought patterns that perpetuate poor sleep, and research consistently shows it outperforms medication for long-term outcomes. In clinical practice, patients completing CBT-I programs have successfully reduced or discontinued various sleep-related substances, including melatonin, benzodiazepines, and antihistamines.18PubMed Central. Outcomes from a combined cognitive behavioral therapy for insomnia (CBT-I) and sleep-related medication and substance use reduction treatment If your current approach involves 40 mg of melatonin and you’re still struggling, a structured behavioral program is far more likely to solve the problem than adding more milligrams.

For people who do benefit from melatonin, revisiting the basics can make a real difference. Try a dose between 0.5 and 5 mg, take it about three hours before you want to sleep rather than right at bedtime, and use a product that has been third-party tested for potency. Those adjustments are backed by stronger evidence than any megadose strategy.